EXHIBIT 11.1
SHERIDAN HEALTHCARE, INC.
Computation of Earnings per Share of Common Stock
(in thousands, except per share amounts)
Nine Months Ended
September 30,
---------------------
1996 1995
Primary Earnings Per Share:
Weighted average shares outstanding............................................ 6,540 2,028
Dilutive effect of outstanding stock options (1)............................... 108 ---
Dilutive effect of convertible securities (1).................................. --- ---
-- -------- ---------
Primary weighted average shares of common stock and
common stock equivalents outstanding........................................ 6,648 2,028
======== =========
Net income (loss) attributable to common stockholders......................... $ 2,696 $ (2,075)
Net income (loss) per share - primary......................................... $ .41 $ (1.02)
Fully Diluted Earnings Per Share:
Weighted average shares outstanding............................................ 6,540 2,028
Dilutive effect of outstanding stock options (1)............................... 108 ---
Dilutive effect of convertible securities (1).................................. --- ---
-- -------- --------
Fully diluted weighted average shares of common stock and
common stock equivalents outstanding........................................ 6,648 2,028
======== ========
Net income (loss) attributable to common stockholders......................... $ 2,696 $ (2,075)
Net income (loss) per share - fully diluted................................... $ .41 $ (1.02)
<FN>
(1) Stock options and convertible securities are excluded from the
earnings per share computation for the nine months ended September 30,
1995 because they would have the effect of decreasing the net loss per
share.
</FN>
18